The brain parenchyma has a type I interferon response that can limit virus spread

Significance The brain parenchyma is considered to be “immune privileged” based upon differences between the innate and adaptive immune responses of the brain and those of the periphery. This work provides a clear demonstration of an innate immune response to direct infection by a virus, a response that is capable of limiting the spread of the virus along neuronal circuitry. The question of the brain parenchyma’s response to a viral infection has implications for the use of viruses as tools by neuroscientists, for vaccine development, and for potential clinical applications. Additionally, the approach used here provides a framework for further examination of the immunologic state of the brain as well as the mechanisms by which encephalitic viruses circumvent this response. The brain has a tightly regulated environment that protects neurons and limits inflammation, designated “immune privilege.” However, there is not an absolute lack of an immune response. We tested the ability of the brain to initiate an innate immune response to a virus, which was directly injected into the brain parenchyma, and to determine whether this response could limit viral spread. We injected vesicular stomatitis virus (VSV), a transsynaptic tracer, or naturally occurring VSV-derived defective interfering particles (DIPs), into the caudate–putamen (CP) and scored for an innate immune response and inhibition of virus spread. We found that the brain parenchyma has a functional type I interferon (IFN) response that can limit VSV spread at both the inoculation site and among synaptically connected neurons. Furthermore, we characterized the response of microglia to VSV infection and found that infected microglia produced type I IFN and uninfected microglia induced an innate immune response following virus injection.

[1]  Cynthia C. Hession,et al.  Div-Seq: Single-nucleus RNA-Seq reveals dynamics of rare adult newborn neurons , 2016, Science.

[2]  G. Palù,et al.  Viral infections of the central nervous system in elderly patients: a retrospective study. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[3]  S. Pacini,et al.  Commentary: Structural and functional features of central nervous system lymphatic vessels , 2015, Front. Neurosci..

[4]  Tom Michoel,et al.  Microglial brain region-dependent diversity and selective regional sensitivities to ageing , 2015, Nature Neuroscience.

[5]  Timothy K. Soh,et al.  Preferential Budding of Vesicular Stomatitis Virus from the Basolateral Surface of Polarized Epithelial Cells Is Not Solely Directed by Matrix Protein or Glycoprotein , 2015, Journal of Virology.

[6]  Johannes E. Schindelin,et al.  The ImageJ ecosystem: An open platform for biomedical image analysis , 2015, Molecular reproduction and development.

[7]  Kevin T. Beier,et al.  Neuroanatomy goes viral! , 2015, Front. Neuroanat..

[8]  Evan Z. Macosko,et al.  Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets , 2015, Cell.

[9]  T. Frensing Defective interfering viruses and their impact on vaccines and viral vectors , 2015, Biotechnology journal.

[10]  Albert C. Huang,et al.  Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier , 2015, Science Translational Medicine.

[11]  S. Weiss,et al.  Upon Intranasal Vesicular Stomatitis Virus Infection, Astrocytes in the Olfactory Bulb Are Important Interferon Beta Producers That Protect from Lethal Encephalitis , 2014, Journal of Virology.

[12]  C. López Defective Viral Genomes: Critical Danger Signals of Viral Infections , 2014, Journal of Virology.

[13]  L. Knoops,et al.  Inefficient Type I Interferon-Mediated Antiviral Protection of Primary Mouse Neurons Is Associated with the Lack of Apolipoprotein L9 Expression , 2014, Journal of Virology.

[14]  A. N. van den Pol,et al.  Long-Distance Interferon Signaling within the Brain Blocks Virus Spread , 2014, Journal of Virology.

[15]  S. Gygi,et al.  Identification of a Unique TGF-β Dependent Molecular and Functional Signature in Microglia , 2013, Nature Neuroscience.

[16]  Ruth R. Montgomery,et al.  Age-dependent dysregulation of innate immunity , 2013, Nature Reviews Immunology.

[17]  S. Whelan,et al.  Uptake of Rabies Virus into Epithelial Cells by Clathrin-Mediated Endocytosis Depends upon Actin , 2013, Journal of Virology.

[18]  Theodore L. Roth,et al.  Type I Interferon Programs Innate Myeloid Dynamics and Gene Expression in the Virally Infected Nervous System , 2013, PLoS pathogens.

[19]  Ian B Hogue,et al.  Virus infections in the nervous system. , 2013, Cell host & microbe.

[20]  C. Hagedorn,et al.  IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease , 2013, PLoS pathogens.

[21]  T. Michiels,et al.  Antiviral Type I and Type III Interferon Responses in the Central Nervous System , 2013, Viruses.

[22]  Andrew D Huberman,et al.  Transsynaptic Tracing with Vesicular Stomatitis Virus Reveals Novel Retinal Circuitry , 2013, The Journal of Neuroscience.

[23]  M. Prinz,et al.  Microglia as modulators of cognition and neuropsychiatric disorders , 2013, Glia.

[24]  Larissa B. Thackray,et al.  IRF-3, IRF-5, and IRF-7 Coordinately Regulate the Type I IFN Response in Myeloid Dendritic Cells Downstream of MAVS Signaling , 2013, PLoS pathogens.

[25]  Tobias Pietzsch,et al.  ImgLib2—generic image processing in Java , 2012, Bioinform..

[26]  H. Weiner,et al.  Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. , 2012, The Journal of clinical investigation.

[27]  B. Heimrich,et al.  Visualizing Production of Beta Interferon by Astrocytes and Microglia in Brain of La Crosse Virus-Infected Mice , 2012, Journal of Virology.

[28]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[29]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[30]  M. Diamond,et al.  Interferon-Induced Ifit2/ISG54 Protects Mice from Lethal VSV Neuropathogenesis , 2012, PLoS pathogens.

[31]  Wei Wu,et al.  Janus kinase 3: the controller and the controlled. , 2012, Acta biochimica et biophysica Sinica.

[32]  A. Thomsen,et al.  Sensing of RNA Viruses: a Review of Innate Immune Receptors Involved in Recognizing RNA Virus Invasion , 2012, Journal of Virology.

[33]  A. Beg,et al.  Defining Emerging Roles for NF-κB in Antivirus Responses: Revisiting the Interferon-β Enhanceosome Paradigm , 2011, PLoS pathogens.

[34]  Kevin T. Beier,et al.  Anterograde or retrograde transsynaptic labeling of CNS neurons with vesicular stomatitis virus vectors , 2011, Proceedings of the National Academy of Sciences.

[35]  S. Whelan,et al.  The Length of Vesicular Stomatitis Virus Particles Dictates a Need for Actin Assembly during Clathrin-Dependent Endocytosis , 2010, PLoS pathogens.

[36]  Kristina J. Nielsen,et al.  Targeting Single Neuronal Networks for Gene Expression and Cell Labeling In Vivo , 2010, Neuron.

[37]  C. Libert,et al.  The X chromosome in immune functions: when a chromosome makes the difference , 2010, Nature Reviews Immunology.

[38]  C. Rueden,et al.  Metadata matters: access to image data in the real world , 2010, The Journal of cell biology.

[39]  S. Whelan,et al.  Subcapsular Sinus Macrophages Prevent CNS Invasion Upon Peripheral Infection With a Neurotropic Virus , 2010, Nature.

[40]  H. Kantarjian,et al.  Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. , 2010, Blood.

[41]  N. Bissonnette,et al.  Spermatozoal transcriptome profiling for bull sperm motility: a potential tool to evaluate semen quality. , 2009, Reproduction.

[42]  S. Rivest Regulation of innate immune responses in the brain , 2009, Nature Reviews Immunology.

[43]  P. Cohen,et al.  Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ϵ , 2009, Journal of Biological Chemistry.

[44]  S. Whelan,et al.  Vesicular Stomatitis Virus Enters Cells through Vesicles Incompletely Coated with Clathrin That Depend upon Actin for Internalization , 2009, PLoS pathogens.

[45]  John Yin,et al.  Multiple-hit inhibition of infection by defective interfering particles. , 2009, The Journal of general virology.

[46]  Steven J M Jones,et al.  Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates , 2008, PLoS pathogens.

[47]  A. N. van den Pol,et al.  Variable Deficiencies in the Interferon Response Enhance Susceptibility to Vesicular Stomatitis Virus Oncolytic Actions in Glioblastoma Cells but Not in Normal Human Glial Cells , 2006, Journal of Virology.

[48]  F. Weber,et al.  Neurons produce type I interferon during viral encephalitis , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[49]  S. Whelan,et al.  An antiviral role for the RNA interference machinery in Caenorhabditis elegans. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  I. Campbell,et al.  Differential Regulation of Interferon Regulatory Factor (IRF)-7 and IRF-9 Gene Expression in the Central Nervous System during Viral Infection , 2005, Journal of Virology.

[51]  G. Cheng,et al.  The host type I interferon response to viral and bacterial infections , 2005, Cell Research.

[52]  Hideo Negishi,et al.  IRF-7 is the master regulator of type-I interferon-dependent immune responses , 2005, Nature.

[53]  M. Trottier,et al.  VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. , 2005, Virology.

[54]  M. Cheeran,et al.  Role of Microglia in Central Nervous System Infections , 2004, Clinical Microbiology Reviews.

[55]  J. Bell,et al.  Vesicular stomatitis virus: re-inventing the bullet. , 2004, Trends in molecular medicine.

[56]  D. Tough,et al.  Links between innate and adaptive immunity via type I interferon. , 2002, Current opinion in immunology.

[57]  J. Hiscott,et al.  Transcriptional Profiling of Interferon Regulatory Factor 3 Target Genes: Direct Involvement in the Regulation of Interferon-Stimulated Genes , 2002, Journal of Virology.

[58]  P. Stevenson,et al.  The immunogenicity of intracerebral virus infection depends on anatomical site , 1997, Journal of virology.

[59]  S. Whelan,et al.  Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[61]  V. Perry,et al.  The acute inflammatory response to lipopolysaccharide in cns parenchyma differs from that in other body tissues , 1992, Neuroscience.

[62]  J. Subak-Sharpe,et al.  The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells. , 1992, The Journal of general virology.

[63]  M. Shin,et al.  Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[64]  D. Cave,et al.  Detection of vesicular stomatitis virus RNA and its defective-interfering particles in individual mouse brains , 1984, Journal of virology.

[65]  S. Pestka,et al.  Specific molecular activities of recombinant and hybrid leukocyte interferons. , 1982, The Journal of biological chemistry.

[66]  A. Banerjee,et al.  Analysis of the RNA species isolated from defective particles of vesicular stomatitis virus. , 1976, The Journal of general virology.

[67]  J. Holland,et al.  Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[68]  H H MERRITT,et al.  Virus infections of the nervous system. , 1950, Bulletin of the New York Academy of Medicine.

[69]  W. Faber The nasal mucosa and the subarachnoid space , 1937 .

[70]  A. Sabin,et al.  INFLUENCE OF HOST FACTORS ON NEUROINVASIVENESS OF VESICULAR STOMATITIS VIRUS , 1937, The Journal of experimental medicine.

[71]  James B. Murphy,et al.  CONDITIONS DETERMINING THE TRANSPLANTABILITY OF TISSUES IN THE BRAIN , 1923, The Journal of experimental medicine.

[72]  N. Osumi,et al.  Neural crest and placode contributions to olfactory development. , 2015, Current topics in developmental biology.

[73]  R. Ransohoff,et al.  Microglia in Health and Disease. , 2015, Cold Spring Harbor perspectives in biology.

[74]  D. Lyles,et al.  Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infection , 2011, Journal of NeuroVirology.

[75]  M. Lafon Immune evasion, a critical strategy for rabies virus. , 2008, Developments in biologicals.

[76]  V. Perry,et al.  What is the blood-brain barrier (not)? , 2007, Trends in immunology.

[77]  V. Perry,et al.  What is immune privilege (not)? , 2007, Trends in immunology.

[78]  C. Aoki,et al.  Pathogenesis of murine encephalitis limited by defective interfering particles. An immunohistochemical study. , 1995, Journal of neurovirology.